Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Therma Bright plans private placement of up to $420,000

Therma Bright plans private placement of up to $420,000

Therma Bright Inc., a company listed on the TSX Venture Exchange and OTCQB, has announced plans to undertake a private placement of up to 14 million of its common shares. The proposed offering would take place at a price of $0.03 per share, resulting in total proceeds of up to $420,000. The company is relying on a minimum pricing exception to issue securities at a price below the usual $0.05 per share on the exchange.

The funds raised from the private placement will be utilized for various purposes. A portion of $120,000 will go towards an initial manufacturing deposit, while $50,000 will be allocated to a comprehensive consumer marketing analysis. Additional funds, up to $42,000, will be used for investor relations activities, and $40,000 will be earmarked to reimburse management expenses and partially cover accrued salaries.

The remaining $168,000 will be directed towards paying off outstanding debts and funding general working capital.

The shares offered for sale will be made available to qualified investors based on exemptions from prospectus and registration requirements under applicable securities legislation. The company may also pay finders’ fees to eligible individuals for their assistance in the offering, provided that all relevant securities laws and TSXV policies are adhered to.

Directors and officers may also participate in the offering, which would be considered a related party transaction and would be exempt from certain formal valuation and minority shareholder approval requirements.

It is important to note that all securities issued under the offering will be subject to a four-month and one-day hold period starting from the date of issuance. Completion of the offering is contingent upon the receipt of all necessary regulatory approvals, including approval from the TSXV. Therma Bright Inc. specializes in the development and investment of advanced diagnostic and medical device technologies.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at investing.com →

More in Finance & Markets

More from Saturday 24 October →